1.02BMarket Cap-10235P/E (TTM)
1.7798High1.6500Low5.64MVolume1.7400Open1.7500Pre Close9.69MTurnover1.44%Turnover RatioLossP/E (Static)586.92MShares1.900052wk High13.59P/B683.82MFloat Cap0.205052wk Low--Dividend TTM393.00MShs Float8.5000Historical High--Div YieldTTM7.42%Amplitude0.0030Historical Low1.7170Avg Price1Lot Size
Perspective Therapeutics Stock Forum
FDA Selects Perspective Therapeutics To Participate In The CDRP Program To Expedite Chemistry, Manufacturing, and Controls Development Readiness For VMT-α-NET in Neuroendocrine Tumors
The Zhitong Finance App learned that the market value of the Richland, Washington-based company has increased about four times this year to reach US$833 million. Amid the radiopharmaceuticals (also...
$NuScale Power(SMR.US)$ $Perspective Therapeutics(CATX.US)$ $Dogness(DOGZ.US)$ $Velo3D(VLD.US)$ $Solidion Technology(STI.US)$
📊⚡️📊
loading...
Dow Jones· 6 mins ago
Click on the 4th tab, “news”.
You are welcome!
No comment yet